About Heliodor Swiecicki Teaching Hospital of the Poznan University of Medical Sciences
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Heliodor Swiecicki Teaching Hospital of the Poznan University of Medical Sciences
During the past decade, Heliodor Swiecicki Teaching Hospital of the Poznan University of Medical Sciences conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Heliodor Swiecicki Teaching Hospital of the Poznan University of Medical Sciences"
#1 collaborator was "Bayer" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Heliodor Swiecicki Teaching Hospital of the Poznan University of Medical Sciences
According to Clinical.Site data, the most researched conditions in "Heliodor Swiecicki Teaching Hospital of the Poznan University of Medical Sciences" are
"Multiple Sclerosis, Relapsing-Remitting" (2 trials). Many other conditions were trialed in "Heliodor Swiecicki Teaching Hospital of the Poznan University of Medical Sciences" in a lesser frequency.
Clinical Trials Intervention Types at Heliodor Swiecicki Teaching Hospital of the Poznan University of Medical Sciences
Most popular intervention types in "Heliodor Swiecicki Teaching Hospital of the Poznan University of Medical Sciences" are "Biological" (2 trials). Other intervention types were less common.
The name of intervention was led by "Interferon beta-1a" (2 trials), "Alemtuzumab" (1 trials), "Alemtuzumab 12 mg" (1 trials) and "Alemtuzumab 24 mg" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Heliodor Swiecicki Teaching Hospital of the Poznan University of Medical Sciences
The vast majority of trials in "Heliodor Swiecicki Teaching Hospital of the Poznan University of Medical Sciences" are
2 trials for "All" genders.
Clinical Trials Status at Heliodor Swiecicki Teaching Hospital of the Poznan University of Medical Sciences
Currently, there are NaN active trials in "Heliodor Swiecicki Teaching Hospital of the Poznan University of Medical Sciences".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Heliodor Swiecicki Teaching Hospital of the Poznan University of Medical Sciences,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Heliodor Swiecicki Teaching Hospital of the Poznan University of Medical Sciences, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".